Global and liver-specific CEACAM1 null mice, and the liver-specific dominant-negative phosphorylation-defective S503A CEACAM1 (L-SACC1) mutants develop secondary insulin resistance due to chronic hyperinsulinemia [15,26,52,53]. The gene discussed is CEACAM1; the disease is Hyperinsulinemia.